Jump to a section
At a glance
- It's inherited: CMT is a group of conditions passed down in families that damage the nerves to the feet, legs and, later, the hands.
- It usually starts in the feet: weakness, high arches, tripping and dulled feeling are common early signs.
- There's no cure, but care aims to keep you moving and manage symptoms.
- Planned exercise is the best-supported step, and overdoing it can make symptoms worse.
- It's slowly progressive, and for most people it doesn't affect life expectancy.
What is Charcot-Marie-Tooth disease, and how common is it?
Charcot-Marie-Tooth disease (CMT) is a group of inherited conditions that damage the peripheral nerves, the nerves outside your brain and spinal cord1. You may also see it called hereditary motor and sensory neuropathy. It's the most common inherited neuropathy2. It's progressive: symptoms slowly get worse and everyday tasks become harder1.
Estimates of how common it is vary. About 1 in 2,500 people is one estimate3, and other counts come out differently4.
There are several main types. In CMT1, the most common, the insulating layer around the nerves (the myelin sheath) slowly breaks down. CMT2 is less common and usually less severe, with the damage in the nerve fibre itself (the axon). CMT3 is rare and severe, with symptoms starting in early childhood5. Most people first show signs by the age of 206.
What causes it, and who gets it?
CMT is caused by faults in genes that damage the peripheral nerves5. No single gene is responsible: dozens have been linked to it73, and the faulty genes can be passed on in several different ways5. The most common cause is an extra copy (a duplication) of a gene called PMP22, behind more than half of all cases7. In some types the faulty genes make the myelin sheath break down. In others the axons are damaged and don't carry signals as strongly5.
Nearly all cases are inherited7, so a family history of CMT is the main known risk. The pattern of inheritance can differ between types.
What does it feel like, how is it diagnosed, and what can make it serious?
CMT usually starts in the feet and lower legs, because the longest nerves are affected first. Weakness often becomes noticeable in the teens or early adulthood, but it can start at any age7. Common early signs are weak muscles that make it hard to lift the foot (foot drop), a high-stepped walk with frequent tripping or falls, and balance problems7. The feet can change shape, with high arches, flat feet or curled toes (hammer toes)78, and foot deformities are common9. Feeling in the feet and lower legs is often dulled for touch, heat and cold, and some people have aching or burning sensations8. Nerve pain can range from mild to severe7. Foot drop and a high-stepped walk raise the risk of tripping, falls and ankle injury89. Later, weakness and numbness can spread to the hands and arms10, and some people develop tremor or scoliosis (a curved spine)10.
CMT is diagnosed from your symptoms, family history and an examination, followed by a nerve conduction test (a test of how well your nerves carry signals)11. High arches with wasting of the lower leg muscles are a prompt to look for a nerve problem, and family history is always explored12. Genetic testing is then done step by step, starting with the PMP22 duplication11.
Some features can mean a more serious form of CMT, though they're rare. Trouble swallowing, vocal cord problems that affect the voice, and difficulty breathing are linked to certain types. Some CMT2 types may involve the vocal cords or the nerve to the diaphragm, which can cause speech or breathing problems7. Breathing problems are a leading cause of serious illness in neuromuscular conditions13. A severe, early-onset form called CMT4D has also been reported with deafness, a curved spine and cognitive delay13. Most types have normal hearing, though CMT4C can bring mild hearing loss14.
Some medicines can make CMT worse. The cancer drug vincristine, and possibly paclitaxel, can occasionally cause a harsher form of nerve damage in people with CMT, so care is advised and nerve function should be closely monitored1516. People with CMT shouldn't be denied effective treatments, such as cancer treatment, that may prolong life or improve health16. Whether nitrous oxide (a gas sometimes used for pain relief) can worsen CMT isn't settled17.
CMT can also sit alongside other nerve conditions. A chronic inflammatory nerve condition (CIDP) has been reported with one common type, and an unusual pattern on a nerve conduction test can point to another or an extra neuropathy12.
What helps first?
There's no cure for CMT, and no medicine that changes its course112. Care focuses on managing symptoms with a team of health professionals, ideally starting early, with personalised exercise advice, adapted orthoses (braces and supports) and assessment for conservative surgery11. The aim is to keep your mobility, flexibility and muscle strength as much as possible, using physical and occupational therapy, braces and other devices2.
Exercise has the most support. Strengthening the muscles that lift the ankle can limit how much weakness progresses in children with CMT1A18. Strength or endurance training may improve function and daily activities in people with CMT, though the role of orthoses isn't completely clear yet, and an agreed exercise programme can't yet be set19. For other outcomes the evidence is weak18.
People with CMT usually can't train at the intensities recommended for healthy people, and high-intensity training is linked with reduced performance and more injuries in neuromuscular disease3. Overexertion, or not following exercise instructions, can make symptoms worse16. It helps to keep exercise planned and personalised, and to follow the instructions you're given.
What helps if that isn't enough?
Nothing beyond first-line care has been shown to change the condition itself. Management stays focused on symptoms, with orthotic adaptation and assessment for conservative surgery such as tendon transfer (where a tendon is moved)11. Braces, other orthopaedic devices and orthopaedic surgery are among the treatments that can help with symptoms2. Some people rely on foot or leg braces to keep walking, and medicines to relieve nerve pain may be prescribed when it is severe7.
Vitamin C (ascorbic acid) gives little worthwhile improvement in fatigue for people with CMT1A, though it seemed safe and well tolerated20.
What is the outlook with CMT?
CMT is slowly progressive, and for most people it doesn't affect life expectancy8. Lower-leg muscles usually weaken further, and hand weakness can make writing, doing up buttons and turning doorknobs harder8. Symptoms vary from person to person, even within a family. It isn't possible to predict when they will start, how fast they'll progress or how severe they'll be10.
Foot drop is the most prominent walking pattern in CMT, and people with CMT fall often9. Taking steps to lower the chance of falls and ankle injury makes sense.
Because CMT is inherited and progressive rather than something that clears and returns, there's no coming back to guard against. Rehabilitation aims to keep you moving and manage symptoms, and no evidence-based rehabilitation protocol can yet be set19.
Common questions
Will I pass CMT on to my children?
CMT is inherited, and the faulty genes can be passed on in several different ways depending on the type. So the chance for your children depends on which type runs in your family. Symptoms also vary, even between relatives with the same condition, so how mild or severe it would be can't be predicted.
Do people with CMT end up in a wheelchair?
Leg and foot problems rarely require a wheelchair. CMT does progress slowly, and weakness and loss of feeling can spread to the hands and arms, which can make writing, doing up buttons and turning doorknobs harder. How quickly it progresses varies from person to person and can't be predicted.
Is pregnancy safe with CMT?
Pregnancy in women with genetic neuromuscular conditions is considered higher-risk. CMT has been linked with preterm labour and caesarean delivery, and care shared between neurologists and obstetricians is advised. This describes risks in general; it doesn't mean every pregnancy will have problems.
Further reading
Want to know more? Charcot-Marie-Tooth disease (CMT) on Clindice
- Charcot-Marie-Tooth disease (CMT)Better Health Channel
- Charcot-Marie-Tooth disease (CMT) | HealthifyHealthify
- Charcot-Marie-Tooth disease: MedlinePlus GeneticsMedlinePlus
- Charcot-Marie-Tooth disease - DiagnosisNHS
Reviewed by Andrew Schox, BSc(Hons) PGradDipPod MPod
Podiatrist
Reviewed 11 November 2026. Next review by 11 November 2027.
Related guides
Sources
(20)
- 1.Charcot-Marie-Tooth diseaseNHS
- 2.Charcot-Marie-Tooth DiseaseNational Institute of Neurological Disorders and Stroke
- 3.Telecoaching: a potential new training model for Charcot-Marie-Tooth patients: a systematic review.Leale I, Di Stefano V, Costanza C et al. · Frontiers in Neurology · 2024
- 4.A meta-analysis on the prevalence of Charcot-Marie-Tooth disease and related inherited peripheral neuropathies.Ma M, Li Y, Dai S et al. · Journal of Neurology · 2023
- 5.Charcot-Marie-Tooth disease - CausesNHS
- 6.Charcot-Marie-Tooth diseaseHealthdirect Australia
- 7.Charcot-Marie-Tooth DiseaseNational Institutes of Health
- 8.Charcot-Marie-Tooth disease | About the Disease | GARDNational Institutes of Health
- 9.The effect of ankle-foot orthoses on gait characteristics in people with Charcot-Marie-Tooth disease: A systematic review and meta-analysis.Kim A, Frecklington M, Philps A et al. · Journal of Foot and Ankle Research · 2024
- 10.Charcot-Marie-Tooth disease - SymptomsNHS
- 11.Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease.Sivera Mascaró R, García Sobrino T, Horga Hernández A et al. · Neurologia · 2025
- 12.PMP22-Related Neuropathies: A Systematic Review.Cesaroni CA, Caiazza L, Pisanò G et al. · Genes · 2025
- 13.Clinical and pathological findings in two Italian siblings of Romani ancestry with charcot-marie-tooth type 4D and review of the current literature.Abati E, Ferrari Aggradi CR, Magri S et al. · Journal of Neuromuscular Diseases · 2026
- 14.Charcot-Marie-Tooth Disease and Hearing Loss: A Systematic Review With Meta-Analysis.Mills JF, Heiland LD, Nguyen SA et al. · Otology & Neurotology · 2024
- 15.Toxic medications in Charcot-Marie-Tooth patients: A systematic review.Cavaletti G, Forsey K, Alberti P · Journal of the Peripheral Nervous System · 2023
- 16.Charcot-Marie-Tooth disease - TreatmentNHS
- 17.Safety of nitrous oxide administration in patients with Charcot-Marie-Tooth disease.Isbister GK, Burns J, Prior F et al. · Journal of the Neurological Sciences · 2008
- 18.Effectiveness of exercise therapy for individuals diagnosed with Charcot-Marie-Tooth disease: A systematic review of randomized clinical trials.Conde RM, Senem I, Dos Santos M et al. · Journal of the Peripheral Nervous System · 2023
- 19.Rehabilitation Management of the Charcot-Marie-Tooth Syndrome: A Systematic Review of the Literature.Corrado B, Ciardi G, Bargigli C · Medicine · 2016
- 20.Interventions for fatigue in peripheral neuropathy.White CM, van Doorn PA, Garssen MPJ et al. · The Cochrane Database of Systematic Reviews · 2014
This is general information, not advice about your own situation. To discuss your issues, book with one of our podiatrists. In an emergency, call 000.
